Shamburek_2016_Circ.Res_118_73

Reference

Title : Safety and Tolerability of ACP-501, a Recombinant Human Lecithin:Cholesterol Acyltransferase, in a Phase 1 Single-Dose Escalation Study - Shamburek_2016_Circ.Res_118_73
Author(s) : Shamburek RD , Bakker-Arkema R , Shamburek AM , Freeman LA , Amar MJ , Auerbach B , Krause BR , Homan R , Adelman SJ , Collins HL , Sampson M , Wolska A , Remaley AT
Ref : Circulation Research , 118 :73 , 2016
Abstract : Shamburek_2016_Circ.Res_118_73
ESTHER : Shamburek_2016_Circ.Res_118_73
PubMedSearch : Shamburek_2016_Circ.Res_118_73
PubMedID: 26628614
Gene_locus related to this paper: human-LCAT

Related information

Gene_locus related to this paper: human-LCAT

Citations formats

Shamburek RD, Bakker-Arkema R, Shamburek AM, Freeman LA, Amar MJ, Auerbach B, Krause BR, Homan R, Adelman SJ, Collins HL, Sampson M, Wolska A, Remaley AT (2016)
Safety and Tolerability of ACP-501, a Recombinant Human Lecithin:Cholesterol Acyltransferase, in a Phase 1 Single-Dose Escalation Study
Circulation Research 118 :73

Shamburek RD, Bakker-Arkema R, Shamburek AM, Freeman LA, Amar MJ, Auerbach B, Krause BR, Homan R, Adelman SJ, Collins HL, Sampson M, Wolska A, Remaley AT (2016)
Circulation Research 118 :73